Analysts Anticipate Apollo Medical Holdings Inc (AMEH) to Announce $0.08 Earnings Per Share

Share on StockTwits

Apollo Medical Holdings Inc (NASDAQ:AMEH) has received an average broker rating score of 2.00 (Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy recommendation.

Analysts have set a one year consensus price target of $25.00 for the company and are predicting that the company will post $0.08 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Apollo Medical an industry rank of 189 out of 255 based on the ratings given to related companies.

A number of equities research analysts have recently commented on the stock. Zacks Investment Research cut shares of Apollo Medical from a “hold” rating to a “sell” rating in a research note on Friday, March 29th. ValuEngine raised shares of Apollo Medical from a “hold” rating to a “buy” rating in a research note on Monday, February 25th.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc grew its stake in shares of Apollo Medical by 184.8% during the 3rd quarter. Vanguard Group Inc now owns 928,911 shares of the company’s stock worth $20,501,000 after purchasing an additional 602,710 shares during the period. BlackRock Inc. grew its stake in shares of Apollo Medical by 8.7% during the 4th quarter. BlackRock Inc. now owns 353,218 shares of the company’s stock worth $7,012,000 after purchasing an additional 28,411 shares during the period. Geode Capital Management LLC grew its stake in shares of Apollo Medical by 14.3% during the 4th quarter. Geode Capital Management LLC now owns 183,445 shares of the company’s stock worth $3,641,000 after purchasing an additional 22,917 shares during the period. Northern Trust Corp grew its stake in shares of Apollo Medical by 33.2% during the 4th quarter. Northern Trust Corp now owns 111,883 shares of the company’s stock worth $2,221,000 after purchasing an additional 27,894 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in shares of Apollo Medical by 63.4% during the 4th quarter. Bank of New York Mellon Corp now owns 59,862 shares of the company’s stock valued at $1,188,000 after buying an additional 23,217 shares in the last quarter. 6.73% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ AMEH opened at $18.84 on Friday. The company has a market cap of $674.81 million, a PE ratio of 64.97, a PEG ratio of 5.54 and a beta of -1.17. Apollo Medical has a 12 month low of $13.01 and a 12 month high of $30.00. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.40 and a current ratio of 2.40.

Apollo Medical Company Profile

Apollo Medical Holdings, Inc, an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Further Reading: Cash Flow Analysis in Stock Selection

Get a free copy of the Zacks research report on Apollo Medical (AMEH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Anticipate Apollo Medical Holdings Inc  to Announce $0.08 Earnings Per Share
Analysts Anticipate Apollo Medical Holdings Inc to Announce $0.08 Earnings Per Share
Confluence Investment Management LLC Boosts Holdings in iShares MBS ETF
Confluence Investment Management LLC Boosts Holdings in iShares MBS ETF
Procter & Gamble  Sets New 12-Month High at $105.57
Procter & Gamble Sets New 12-Month High at $105.57
SPINDLE Reaches 24-Hour Trading Volume of $31,486.00
SPINDLE Reaches 24-Hour Trading Volume of $31,486.00
PlusOneCoin Trading Up 28.5% Over Last 7 Days
PlusOneCoin Trading Up 28.5% Over Last 7 Days
Resolution Capital Ltd Decreases Stake in Washington Real Estate Investment Trust
Resolution Capital Ltd Decreases Stake in Washington Real Estate Investment Trust


© 2006-2019 Ticker Report